If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

Share Price is delayed by 15 minutes
Get Live Data
1,875.00    9.00 (0.48%)
Bid:
1,878.00
Ask:
1,880.00
Spread: 2.00 (0.106%)
Market Cap: £6.01b
HSX Live PriceLast checked at - London Stock Exchange

Intraday Hiscox Share Chart

D Share purchase by the Company

7 Apr 2014 10:06

RNS Number : 1990E
Hiscox Ltd
07 April 2014
 



Announcement of purchase of D Shares by the Company, 7 April 2014

 

Purchase of D Shares

 

Hamilton, Bermuda (7 April 2014) - Further to the purchase by UBS Limited, acting as principal (and not as agent, nominee or trustee), from Shareholders of 93,647,894 D Shares pursuant to the Purchase Offer (as announced earlier today by the Company), such D Shares have today subsequently been purchased by the Company from UBS Limited pursuant to the Option Agreement and have been cancelled.

 

The price paid by the Company to UBS Limited for this purchase was 50 pence per D Share.

 

Further details of the Return of Capital are contained in the Circular. Terms used in this announcement have the same meaning as set out in the Circular.

 

For further information:

 

Hiscox Ltd

Jeremy Pinchin, Group Company Secretary +1 441 278 8300

Kylie O'Connor, Head of Group Communications, London +44 (0)20 7448 6656

 

This announcement does not constitute, or form part of, an offer to sell or the solicitation of an offer to subscribe for or buy any securities, nor the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issue or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.

 

The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.

 

No application will be made to the UK Listing Authority or to the London Stock Exchange for any of the C Shares, D Shares, C Deferred Shares or Deferred Shares to be admitted to the Official List or to trading on the London Stock Exchange's main market for listed securities, nor will the C Shares, D Shares, C Deferred Shares or Deferred Shares be admitted to trading on any other recognised investment exchange.

 

None of the C Shares, D Shares, C Deferred Shares, Deferred Shares or New Ordinary Shares have been or will be registered under the United States Securities Act of 1933 as amended (the "US Securities Act") or the state securities laws of the United States and none of them may be offered or sold in the United States unless pursuant to a transaction that has been registered under the US Securities Act and the relevant state securities laws or that is not subject to the registration requirements of the US Securities Act or such laws, either due to an exemption therefrom or otherwise.

 

None of the C Shares, D Shares, C Deferred Shares, Deferred Shares, New Ordinary Shares or this announcement or the Circular has been approved, disapproved or otherwise recommended by any US federal or state securities commission, including the U.S. Securities and Exchange Commission, or other regulatory authority or any non-US securities commission or regulatory authority, nor have such authorities confirmed the accuracy or determined the adequacy of this announcement or the Circular. Any representation to the contrary is a criminal offence in the United States.

 

UBS Limited is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority in the United Kingdom and acting as financial adviser and corporate broker exclusively for the Company and for no one else in connection with the matters referred to in this announcement or the Circular and will not be responsible to anyone other than the Company (whether or not a recipient of this announcement or the Circular) for providing the protections afforded to clients of UBS Limited nor for providing advice in relation to the matters referred to in this announcement or the Circular or any other matter referred to in this announcement or the Circular. Persons other than the Company are recommended to seek their own financial and professional advice.

 

Apart from the responsibilities and liabilities, if any, which may be imposed on UBS Limited by the Financial Services and Markets Act 2000 (as amended) or the regulatory regime established thereunder, UBS Limited accepts no responsibility or liability, whether arising in tort, contract or otherwise, to Shareholders for the contents of this announcement or the Circular or for any other statement made in connection with the Company, the proposed Return of Capital or the Resolutions. 

 

This announcement has been issued by, and is the sole responsibility of, the Company.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUBRKRSAASRRR
Date   Source Headline
6th Jul 20267:00 amRNSTransaction in Own Shares
1st Jul 20264:39 pmRNSTotal Voting Rights
29th Jun 20267:00 amRNSTransaction in Own Shares
22nd Jun 20267:00 amRNSTransaction in Own Shares
17th Jun 20264:27 pmRNSDirector/PDMR Shareholding
15th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 202612:11 pmRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSNotice of dividend currency exchange rate
26th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20262:52 pmRNSNotification of transactions
15th May 20262:43 pmRNSNotification of transactions
14th May 20265:09 pmRNSHiscox 2026 AGM Results
14th May 20265:00 pmRNSSyndicates 33 and 6104 – results and estimates
14th May 20264:53 pmRNSDirector Declaration
11th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSQ1 2026 Trading Statement
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20261:57 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202611:57 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20262:20 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20261:05 pmRNSNotice of 2026 AGM and 2025 Annual Report
16th Mar 20261:05 pmRNSNotice of 2026 AGM and 2025 Annual Report
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20269:30 amRNSSyndicates 33 and 6104 – results and estimates
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 202612:50 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:01 amRNSAnnouncement of share repurchase programme
25th Feb 20267:00 amRNSFull Year Results
2nd Feb 202612:33 pmRNSTotal Voting Rights
15th Jan 20267:00 amRNSTR-1: Standard notification of major shareholding
9th Jan 20263:39 pmRNSTR-1: Standard notification of major shareholding
9th Jan 20267:00 amRNSTR-1: Standard notification of major shareholding
2nd Jan 20263:25 pmRNSHiscox Ltd - Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.